The level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to lamivudine

被引：14

作者：

Ambrose, Z

Julias, JG

Boyer, PL

KewalRamani, VN

Hughes, SH

机构：

[1] NCI, Frederick, MD 21702 USA

[2] SAIC Frederick, HIV Drug Resistance Program, Frederick, MD 21702 USA

[3] SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA

来源：

JOURNAL OF VIROLOGY | 2006年 / 80卷 / 05期

关键词：

D O I：

10.1128/JVI.80.5.2578-2581.2006

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We investigated the relationship between the level of reverse transcriptase (RT) in human immunodeficiency virus type 1 (HIV-1) particles and susceptibility to normucleoside reverse transcriptase inhibitors (NNRTIs). HIV-1 virions containing different active levels of RT were generated. Susceptibility to the NNRT1s efavirenz and nevirapine was inversely proportional to the level of enzymatically active RT. However, the sensitivity of HIV-1 to the nucleoside analog 3TC was not affected by the level of RT per particle. These data indicate that the susceptibility of HIV-1 to NNRT1s is influenced by RT activity.

引用

收藏

页码：2578 / 2581

页数：4

相关论文

共 19 条

[1] In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques [J].

Ambrose, Z ;

Boltz, V ;

Palmer, S ;

Coffin, JM ;

Hughes, SH ;

KewalRamani, VN .

JOURNAL OF VIROLOGY, 2004, 78 (24) :13553-13561

[2] Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT):: Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase [J].

Arion, D ;

Kaushik, N ;

McCormick, S ;

Borkow, G ;

Parniak, MA .

BIOCHEMISTRY, 1998, 37 (45) :15908-15917

[3] Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase [J].

Boyer, PL ;

Sarafianos, SG ;

Arnold, E ;

Hughes, SH .

JOURNAL OF VIROLOGY, 2001, 75 (10) :4832-4842

[4] Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage [J].

Cecilia, D ;

Kewalramani, VN ;

O'Leary, J ;

Volsky, B ;

Nyambi, P ;

Burda, S ;

Xu, S ;

Littman, DR ;

Zolla-Pazner, S .

JOURNAL OF VIROLOGY, 1998, 72 (09) :6988-6996

[5]

de la Carrière LC, 1999, J VIROL, V73, P3455

[6]

GARCIALERMA G, 1998, J INFECT DIS, V177, P1221

[7] The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis [J].

Götte, M ;

Arion, D ;

Parniak, MA ;

Wainberg, MA .

JOURNAL OF VIROLOGY, 2000, 74 (08) :3579-3585

[8] The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis [J].

Haubrich, RH ;

Kemper, CA ;

Hellmann, NS ;

Keiser, PH ;

Witt, MD ;

Forthal, DN ;

Leedom, J ;

Leibowitz, M ;

Whitcomb, JM ;

Richman, D ;

McCutchan, JA .

AIDS, 2002, 16 (15) :F33-F40

[9] Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase [J].

Julias, JG ;

Ferris, AL ;

Boyer, PL ;

Hughes, SH .

JOURNAL OF VIROLOGY, 2001, 75 (14) :6537-6546

[10] Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates [J].

Marozsan, AJ ;

Fraundorf, E ;

Abraha, A ;

Baird, H ;

Moore, D ;

Troyer, R ;

Nankja, I ;

Arts, EJ .

JOURNAL OF VIROLOGY, 2004, 78 (20) :11130-11141